Alzamend Neuro Inc (ALZN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.36M |
| Enterprise Value | -1.58M |
| P/E Ratio | -0.26 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.06 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.14 |
| Fiscal Year | April 30, 2025 |
| Most Recent Quarter | January 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.74 |
| Return On Equity | -1.77 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -4.45M |
| Net Income | -4.51M |
| Diluted EPS | -11.32 |
| Total Cash | 2.71M |
| Total Cash/Share | 0.71 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 1.99 |
| Book Value Per Share | 0.57 |
| 52-Week Change | -62.66 |
| 52-Week High | 3.6 |
| 52-Week Low | 0.84 |
| Moving Average 50 Days | 1.15 |
| Moving Average 200 Days | 1.79 |
| Average Volume | 151,827 |
| Shares Outstanding | 3.14M |
| % Held by Institutions | 3.04 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:9 |
| Last Split Date | May 12, 2025 |